JP5947085B2 - 血小板活性試験のための対照及びキット - Google Patents

血小板活性試験のための対照及びキット Download PDF

Info

Publication number
JP5947085B2
JP5947085B2 JP2012080672A JP2012080672A JP5947085B2 JP 5947085 B2 JP5947085 B2 JP 5947085B2 JP 2012080672 A JP2012080672 A JP 2012080672A JP 2012080672 A JP2012080672 A JP 2012080672A JP 5947085 B2 JP5947085 B2 JP 5947085B2
Authority
JP
Japan
Prior art keywords
platelet function
lyophilized product
control
platelet
whole blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012080672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012220493A (ja
JP2012220493A5 (enExample
Inventor
レヒナー アンドレアス
レヒナー アンドレアス
ツァンダー ノルベルト
ツァンダー ノルベルト
Original Assignee
シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング
シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング, シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング filed Critical シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング
Publication of JP2012220493A publication Critical patent/JP2012220493A/ja
Publication of JP2012220493A5 publication Critical patent/JP2012220493A5/ja
Application granted granted Critical
Publication of JP5947085B2 publication Critical patent/JP5947085B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/25—Reference solutions for assays of biological material containing added polymers to stabilise biological material against degradation or maintain viscosity or density, e.g. gelatin, polyacrylamides or polyvinyl alcohol
    • G01N2496/30—Polyethylene glycol, e.g. PEG

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2012080672A 2011-04-04 2012-03-30 血小板活性試験のための対照及びキット Active JP5947085B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11160934A EP2508892A1 (de) 2011-04-04 2011-04-04 Kontrollen und Kit für Thrombozytenaktivitätsteste
EP11160934.3 2011-04-04

Publications (3)

Publication Number Publication Date
JP2012220493A JP2012220493A (ja) 2012-11-12
JP2012220493A5 JP2012220493A5 (enExample) 2015-03-05
JP5947085B2 true JP5947085B2 (ja) 2016-07-06

Family

ID=44123219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012080672A Active JP5947085B2 (ja) 2011-04-04 2012-03-30 血小板活性試験のための対照及びキット

Country Status (4)

Country Link
US (1) US8741873B2 (enExample)
EP (2) EP2508892A1 (enExample)
JP (1) JP5947085B2 (enExample)
ES (1) ES2635196T3 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6012455B2 (ja) * 2012-12-21 2016-10-25 シーメンス ヘルスケア ダイアグノスティクス プロダクツ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 血小板機能を測定するシステムにおいて測定結果を標準化する方法
CN105652022B (zh) * 2015-12-31 2017-10-10 浙江盛域医疗技术有限公司 血栓弹力图仪质控品及其制备方法
US20190049428A1 (en) * 2016-02-17 2019-02-14 Sony Corporation Platelet aggregability analyzing device, platelet aggregability analyzing system, platelet aggregability analyzing program, and method of analyzing platelet aggregability
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
JP7230429B2 (ja) 2018-10-25 2023-03-01 ソニーグループ株式会社 血小板凝集能解析装置、血小板凝集能解析方法及び血小板凝集能解析システム
CN113597532B (zh) 2019-03-14 2023-02-17 泰尔茂比司特生物技术有限公司 冻干容器填充固定装置、系统及使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358394A (en) 1979-05-07 1982-11-09 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability
US4338564A (en) 1979-06-11 1982-07-06 R & D Systems, Inc. Hematology control composition and methods for its use
DE19634313A1 (de) * 1996-08-24 1998-02-26 Behringwerke Ag Methode zur Stabilisierung von Plättchen
AU754936B2 (en) * 1996-11-27 2002-11-28 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7790362B2 (en) * 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
DE10360628A1 (de) * 2003-12-19 2005-07-21 Dade Behring Marburg Gmbh Kontrollplasma für Thrombinaktivitätstests
US7811558B2 (en) * 2004-08-12 2010-10-12 Cellphire, Inc. Use of stabilized platelets as hemostatic agent
CN101072506B (zh) * 2004-08-12 2010-05-12 塞尔菲乐有限公司 制备冻干血小板的方法、包括冻干血小板的组合物和使用方法
JP5478884B2 (ja) * 2005-09-26 2014-04-23 ライフセル コーポレーション 乾燥血小板組成物
DE102006020385A1 (de) 2006-04-28 2007-10-31 Dade Behring Marburg Gmbh Verfahren und Vorrichtung zur Bestimmung der Thrombozytenfunktion unter Flussbedingungen
DE102006020386A1 (de) * 2006-04-28 2007-10-31 Dade Behring Marburg Gmbh Verfahren zur Bestimmung der Thrombozytenfunktion unter Flussbedingungen

Also Published As

Publication number Publication date
US20120252044A1 (en) 2012-10-04
EP2508892A1 (de) 2012-10-10
JP2012220493A (ja) 2012-11-12
ES2635196T3 (es) 2017-10-02
US8741873B2 (en) 2014-06-03
EP2508893B1 (de) 2017-04-26
EP2508893A1 (de) 2012-10-10

Similar Documents

Publication Publication Date Title
Smith et al. Correlation of hematocrit, platelet concentration, and plasma coagulation factors with results of thromboelastometry in canine whole blood samples
JP5947085B2 (ja) 血小板活性試験のための対照及びキット
György et al. Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube
US8097403B2 (en) Freeze-dried platelets, method of making and method of use as a diagnostic agent
CN101072506B (zh) 制备冻干血小板的方法、包括冻干血小板的组合物和使用方法
CN103384496B (zh) 含有血液稳定剂的血液收集装置
DK2684056T3 (en) Method of monitoring anticoagulant therapy
JP6526717B2 (ja) 線維素溶解及び線溶亢進を検出するための方法及び試薬
JP5628409B2 (ja) 試験液の凝固特性を測定するための組成物
US8895259B2 (en) Method for determination of platelet function under flow conditions
CN102980993A (zh) 血小板聚集功能检测试剂盒及检测方法
JP2007298511A (ja) 血小板機能の流動状態下での測定方法および装置
US20060035383A1 (en) Dry platelet preparations for use in diagnostics
US20110183311A1 (en) Dry platelet preparations for use in diagnostics
CN104914256B (zh) 用作体外试验中异常凝血对照血浆的组合物
Ban et al. A point-of-care microfluidic channel-based device for rapid and direct detection of fibrinogen in whole blood
Mischke Laboratory evaluation and interpretation of haemostasis in small animals
Baumgarten et al. Changes of platelet function and blood coagulation during short-term storage of CPDA-1-stabilised ovine blood
JP6012455B2 (ja) 血小板機能を測定するシステムにおいて測定結果を標準化する方法
Meyers et al. Equine Hemostasis: Description, Evaluation, and Alteration
Peng An eBook on Biomedical Sciences
US20130008236A1 (en) Method for standardizing measured results in a system for measuring thrombocyte function
Khalifa Determination of Oral Contraceptive pills Effect on Coagulation Profile among Sudanese women in Shendi locality
Weitzel et al. Laboratory-based tests of blood clotting

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150119

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20151022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151210

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160506

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160602

R150 Certificate of patent or registration of utility model

Ref document number: 5947085

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250